Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03921619 · ClinicalTrials.gov registry record · NA

Sling Use and Functional Mobility in a Geriatric Population

A NA study of Mobility Limitation, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT03921619 is a NA study of Mobility Limitation that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 50 participants, below the 254-participant average among 28 other Mobility Limitation trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03921619, a NA study of Mobility Limitation, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Shoulder slings are commonly worn after shoulder surgery. In geriatric patients, painstaking care is taken to reduce any factors that may increase the chance of experiencing a fall. Currently, it is not understood if wearing a sling affects someone's general gait and balance.

Conditions Studied

Interventions

  • DEVICE Shoulder Sling

Study Locations (1)

Alabama

  • UAB Hospital Highlands - Birmingham

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2020-02-15
Est. Completion 2021-10-30
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT03921619

The ClinicalTrials.gov registry entry for NCT03921619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 254-participant average among 28 other Mobility Limitation trials with a reported enrollment target (80% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Mobility Limitation appearing as the primary indexed condition, and to 1 intervention - of which Shoulder Sling is the first listed.

NCT03921619 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT03921619 about?

NCT03921619 is a clinical study titled "Sling Use and Functional Mobility in a Geriatric Population". Shoulder slings are commonly worn after shoulder surgery. In geriatric patients, painstaking care is taken to reduce any factors that may increase the chance of experiencing a fall. Currently, it is not understood if wearing a sling affects someone's general gait and balance.

What is the current status of trial NCT03921619?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2020-02-15. Estimated completion is 2021-10-30.

What conditions does trial NCT03921619 study?

This clinical trial studies the following conditions: Mobility Limitation.

What interventions are being tested in trial NCT03921619?

The interventions under investigation include: Shoulder Sling (DEVICE).

Who is sponsoring clinical trial NCT03921619?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03921619 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mobility Limitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.